利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

25 条记录 (耗时 0.036 秒)

    5-Substituted pyrimidine derivatives of conformationally locked nucleoside analogues
    1.
    发明授权
    5-Substituted pyrimidine derivatives of conformationally locked nucleoside analogues 有权
    5取代的构象锁定核苷类似物的嘧啶衍生物

    公开(公告)号：US07009050B2

    公开(公告)日：2006-03-07

    申请号：US10346762

    申请日：2003-01-15

    申请人： Victor E. Marquez ,  Pamela L. Russ

    发明人： Victor E. Marquez ,  Pamela L. Russ

    IPC分类号： C07D239/54 ,  C07D239/553 ,  A61K31/513 ,  A61P31/22

    CPC分类号： C07D239/54 ,  C07D239/553

    摘要： The embodiments described herein concern 5-substituted pyrimidine derivatives of conformationally locked nucleoside analogues and to the use of these derivatives as anti-viral and anti-cancer agents. The compounds are of the formula: wherein B is uracil-1-yl or cytosin-1-yl having a 5-substituent selected from halogen, alkyl, alkenyl, and alkynyl, with the proviso that where B is uracil-1-yl, the 5-substituent is not methyl. The compounds are useful in the treatment of Herpes simplex virus (HSV).

    摘要翻译： 本文描述的实施方案涉及构象锁定核苷类似物的5-取代嘧啶衍生物以及这些衍生物作为抗病毒和抗癌剂的用途。 所述化合物具有下式：其中B是尿嘧啶-1-基或具有选自卤素，烷基，烯基和炔基的5-取代基的细胞蛋白-1-基，条件是其中B是尿嘧啶-1-基， 5-取代基不是甲基。 该化合物可用于治疗单纯疱疹病毒（HSV）。

    2'-Fluorofuranosyl derivatives and methods for preparing 2'-fluoropyrimidine and 2'-fluoropurine nucleosides
    7.
    发明授权
    2'-Fluorofuranosyl derivatives and methods for preparing 2'-fluoropyrimidine and 2'-fluoropurine nucleosides 失效
    2'-氟呋喃糖苷衍生物及其制备方法2'-氟嘧啶核苷和2'-氟嘌呤核苷

    公开(公告)号：US5817799A

    公开(公告)日：1998-10-06

    申请号：US556713

    申请日：1990-07-23

    申请人： Victor E. Marquez ,  John S. Driscoll ,  Ronald J. Wysocki, Jr. ,  Magbool A. Siddiqui

    发明人： Victor E. Marquez ,  John S. Driscoll ,  Ronald J. Wysocki, Jr. ,  Magbool A. Siddiqui

    IPC分类号： C07H1/00 ,  A61K31/70 ,  A61K31/7042 ,  A61K31/7052 ,  A61K31/7064 ,  A61K31/7072 ,  A61K31/7076 ,  A61P31/12 ,  A61P31/18 ,  C07H13/08 ,  C07H15/04 ,  C07H15/203 ,  C07H19/06 ,  C07H19/10 ,  C07H19/16 ,  C07H23/00

    CPC分类号： C07H23/00 ,  C07H19/10 ,  C07H19/16

    摘要： A method of preparing a 2'-fluoro compound of the formula ##STR1## where B is selected from the group consisting of purines and pyrimidines, both of which may be substituted, comprises reacting a compound of the formula II(a) or II(b) ##STR2## where R and R' are as defined in the specification with an acid halide under conditions effective to obtain a halide of the formula ##STR3## where X is a halogen. A silane of the formula B-Si (R").sub.3 where R" is as defined in the specification, is added to this product (III) under conditions effective to obtain a compound of the formula (IV) ##STR4## The compound of formula (IV) is reacted with a reagent selected from the group consisting of ammonia, BCl.sub.3 and ((C.sub.1 -C.sub.10)alkyl).sub.4 NF, under conditions effective to obtain the compound of formula (I). The compounds of formula (I) resulting from these methods exhibit anti-HIV activities and are useful for therapy against the HIV virus.

    摘要翻译： 制备式（I）的2'-氟化合物的方法，其中B选自嘌呤和嘧啶，它们都可以被取代，包括使式II（a）的化合物与式 （IIa）（IIb）其中R和R'如本说明书中所定义，与有效得到式（III）的卤化物的条件下的酰卤相同，其中X 是卤素。 在有效获得式（IV）化合物的条件下，将式B-Si（R“）3的硅烷（其中R”如说明书中所定义）加入到该产物（III）中 IV）在有效获得式（I）化合物的条件下，使式（IV）化合物与选自氨，BCl 3和（（C 1 -C 10）烷基）4 NF的试剂反应。 由这些方法得到的式（I）化合物表现出抗HIV活性，可用于治疗HIV病毒。

    Anaphylactic inhibitors
    10.
    发明授权
    Anaphylactic inhibitors 失效
    过敏性抑制剂

    公开(公告)号：US4167577A

    公开(公告)日：1979-09-11

    申请号：US884490

    申请日：1978-03-08

    申请人： Victor E. Marquez

    发明人： Victor E. Marquez

    IPC分类号： C07D487/04 ,  A61K31/415

    CPC分类号： C07D487/04 ,  C07C45/68

    摘要： Compounds for use as orally active anaphylactic inhibitors are disclosed. The compounds are trans-2,3b,4,5,7,8b,9,10-octahydronaphto [1,2-c:5,6-c'] dipyrazoles which may be substituted in both of the pyrazole rings. Also disclosed are intermediate compounds which are the corresponding trans-2,6-bis (hydroxymethylene) decalin-1,5-diones.

    摘要翻译： 公开了用作口服活性过敏性抑制剂的化合物。 这些化合物是可在两个吡唑环中被取代的反式-2,3b，4,5,7,8b，9,10-八氢萘并[1,2-c：5,6-c']二吡唑。 还公开了作为相应的反式-2,6-双（羟基亚甲基）十氢化萘-1,5-二酮的中间体化合物。